Quest Diagnostics Incorporated Company Profile and SWOT Analysis

Document Sample
Quest Diagnostics Incorporated Company Profile and SWOT Analysis Powered By Docstoc
					Quest Diagnostics Incorporated

_________________________________________________________________________________



Quest Diagnostics Incorporated                                                Financial Snapshot

                                                                              Operating Performance
Fast Facts
                                     3 Giralda Farms, Madison, 07940,United   The company reported revenues of US$7,368.93
Headquarters Address
                                     States of America                        million during 2010, with a CARC of 4.13% during
                                                                              2006–2010. Its revenue declined at an annual rate of
Telephone                            + 1 201 3935000
                                                                              1.16% over the previous fiscal year. In 2010, the
                                                                              company recorded an operating margin of 17.58%, as
Fax                                  + 1 201 4624169                          against 17.95% in 2009.

Website                              www.questdiagnostics.com
                                                                              Revenue and Margins
Ticker Symbol, Stock Exchange        DGX, New York Stock Exchange

Number of Employees                  43,000

Fiscal Year End                      December

Revenue (in US$ million)             7,368.93




SWOT Analysis

Strengths                            Weaknesses                               Return on Equity

Diversified Facilities               Outstanding Debt                         The company recorded a return on equity (ROE) of
                                                                              17.87% for 2010, as compared to its peers,
                                                                              Laboratory Corporation of America Holdings (Ticker:
Strong Financial Performance         Pending lawsuits/Legal Proceedings       LH), Bio-Reference Laboratories, Inc. (Ticker: BRLI)
                                                                              and PAREXEL International Corporation (Ticker:
Strong Market Position                                                        PRXL), which recorded ROEs of 22.63%, 17.31% and
                                                                              9.45% respectively. The company reported an
                                                                              operating margin of 17.58% in 2010.
Wide Range of Services

Opportunities                        Threats                                  Return on Equity


Changing Demographics                Government Regulations

                                     Government Reimbursements from
Emerging markets
                                     Medicare & Medicaid

Growing Diagnostic Testing Market    Uncertain R&D Outcomes

Growth in the Prevalence of Cancer




                                                                              Liquidity Position

                                                                              The company reported a current ratio of 1.32 in 2010,
                                                                              as compared to its peers, Laboratory Corporation of
                                                                              America Holdings, Bio-Reference Laboratories, Inc.
                                                                              and PAREXEL International Corporation, which
                                                                              recorded current ratios of 1.02, 2.07 and 1.32
                                                                              respectively. As of December 2010, the company
                                                                              recorded cash and short-term investments of worth
                                                                              US$449.30 million, against US$349.00 million current
                                                                              debt. The company reported a debt to equity ratio of
                                                                              0.74 in 2010 as compared to its peers, Laboratory
                                                                              Corporation of America Holdings, Bio-Reference
                                                                              Laboratories, Inc. and PAREXEL International
                                                                              Corporation, which recorded debt to equity ratios of
                                                                              0.89, 0.25 and 0.49 respectively.




___________________________________________________________________________________________

Quest Diagnostics Incorporated - SWOT Profile                                                                        Page 1
Quest Diagnostics Incorporated

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1       Company Overview ................................................................................................................................................5
    1.2       Business Description ..............................................................................................................................................5
    1.3       Major Products and Services .................................................................................................................................6
2     Analysis of Key Performance Indicators ............................................................................................... 7
    2.1       Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................7
    2.2       Key Financial Performance Indicators .................................................................................................................10
      2.2.1       Revenue and Operating Profit .........................................................................................................................10
      2.2.2       Asset, Liabilities and Capex .............................................................................................................................11
      2.2.3       Net Debt vs. Gearing Ratio ..............................................................................................................................12
      2.2.4       Operational Efficiency ......................................................................................................................................13
      2.2.5       Solvency ..........................................................................................................................................................14
      2.2.6       Valuation ..........................................................................................................................................................15
    2.3       Competitive Benchmarking ..................................................................................................................................16
      2.3.1       Market Capitalization .......................................................................................................................................17
      2.3.2       Efficiency ..........................................................................................................................................................18
      2.3.3       Capital Expenditure ..........................................................................................................................................19
      2.3.4       Valuation ..........................................................................................................................................................20
      2.3.5       Turnover – Inventory and Asset .......................................................................................................................21
      2.3.6       Liquidity ............................................................................................................................................................22
3     Mergers & Acquisitions and Partnerships ........................................................................................... 23
    3.1       M&A and Partnerships Strategy ...........................................................................................................................23
4     SWOT 
				
DOCUMENT INFO
Description: This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business. ICD Research's "Quest Diagnostics Incorporated: Company Profile and SWOT Analysis" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
BUY THIS DOCUMENT NOW PRICE: $99 100% MONEY BACK GUARANTEED
PARTNER ICD Research
With emphasis on Insight, Consultancy and Delivery, iCD Research is a full-service, online market research agency. iCD Research is able to take advantage of all of the efficiencies and benefits that the Internet brings to offer proven research methodologies with fast turnaround and accurate results. iCD Research specialises in qualitative research for large finance, media, retail and entertainment clients. Market leaders in online focus groups, iCD Research has unleashed the full scale of the Internet to run focus groups across the globe for its major institutional clients. Utilising its sister organisation, The iD Factor, iCD Research also delivers strong quantitative research, ranging from ongoing consumer confidence studies through to consumer surveys throughout Europe and Asia. With its roots firmly in research, iCD Research doesn’t limit itself to only utilising online methods as the philosophy at the company is to match the methodology to the respondent. Yet the scale and speed of online research give iCD Research a cutting edge that has lead to tremendous, triple-figure percentage growth over the past two years. iCD Research is headquartered in London, with operational offices in the US and Australia to ensure that it is offering an unparalleled 24 hour service to its clients.